Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Brain Surgery
Excision of skull base tumor
What excision of skull base tumor involves, how open craniotomy and endoscopic endonasal approaches differ, clinical evidence on resection and neurological preservation, approximate costs in Turkey compared with the UK, US and Germany, recovery milestones in hospital and at home, potential risks and how to evaluate a specialist neurosurgical team.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Brain Surgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for Excision of Skull Base Tumor
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
Excision of skull base tumor in Turkey: what it is and surgical aims
Excision of skull base tumor is a specialised neurosurgical operation to remove growths located along the floor of the cranium, the anatomical boundary separating the brain from the facial structures and sinuses. These complex lesions—including meningiomas, pituitary adenomas, vestibular schwannomas (acoustic neuromas), chordomas and craniopharyngiomas—arise adjacent to vital arteries and cranial nerves controlling vision, hearing and facial movement. Patients researching excision of skull base tumor Turkey access advanced microsurgical facilities at transparent international prices. For an overview of neurological care, see our guide to neurosurgery treatments in Turkey.
The surgical aim is maximal safe resection: removing the tumor while preserving neurological function. When a benign tumor adheres to critical blood vessels or nerves, intentional partial excision followed by observation or targeted radiosurgery provides the safest clinical balance.
How do surgical approaches to skull base tumors work?
Surgical approaches depend on tumor location, size and pathology. Routes divide broadly into minimally invasive endoscopic endonasal procedures and open microsurgical craniotomies.
Endoscopic approaches access central lesions through the natural corridors of the nostrils and sinuses without external facial incisions. Guided by high-definition endoscopes and computerised navigation systems, a neurosurgeon and an ENT surgeon collaborate to remove midline tumors such as pituitary adenomas and chordomas. For details, see our guide to transnasal resection of tumor.
Open craniotomies access lateral or posterior regions of the skull floor. The neurosurgeon creates a temporary bone opening (such as a pterional, orbitozygomatic or retrosigmoid approach) to reach the pathology with minimal brain retraction, using operating microscopes and ultrasonic aspirators to detach the tumor safely.
A vital final step is watertight skull base reconstruction. To prevent cerebrospinal fluid (CSF) leaks into the sinuses, surgeons rebuild the cranial floor using vascularised tissue flaps, fascial grafts, surgical sealants and occasionally temporary lumbar spinal drains.
Does surgical excision of skull base tumors cure the condition?
Curative potential depends on tumor pathology, location and whether complete removal is achievable without neurological injury. For benign lesions such as standard pituitary adenomas, vestibular schwannomas and convex meningiomas, complete surgical excision provides a definitive, long-term cure with high local control rates.
However, when a tumor encases major cerebral arteries or invades bone, complete resection carries high risks of stroke or nerve deficit. In these cases, neurosurgeons perform deliberate partial resection, treating residual tissue with focused stereotactic radiosurgery (such as Gamma Knife or CyberKnife) to achieve disease control while protecting neurological function. Malignant tumors require combined treatment, pairing surgical debulking with adjuvant radiotherapy and chemotherapy.
Excision of skull base tumor cost in Turkey compared with the UK, US and Germany
Skull base surgery requires extensive theatre resources, specialised surgical teams and neuro-intensive care. The figures below show approximate price ranges for comprehensive surgical management across key countries. These reflect typical procedural fees, pre-operative diagnostics, theatre time and inpatient care; they are not hospital-specific quotations.
| Country | Approximate cost range |
|---|---|
| Turkey | €15,000 – €35,000 |
| United Kingdom | €30,000 – €70,000 |
| United States | €55,000 – €165,000 |
| Germany | €28,000 – €65,000 |
Clinical variables shape the excision of skull base tumor cost. Complex procedures requiring combined neurosurgical and ENT teams, operating times exceeding eight hours, intraoperative MRI, or extended neuro-ICU monitoring increase total fees. Factors influencing excision of skull base tumor price also include reconstruction grafts and post-operative physiotherapy. In Turkey, international packages typically cover the operation, anaesthesia, hospital stay, intensive care, routine imaging, medication and airport transfers. Patients should request an itemised written estimate following imaging review.
Endoscopic endonasal surgery, open craniotomy or stereotactic radiosurgery?
Choosing the appropriate treatment depends on tumor location, diameter, cranial nerve involvement and the patient's general health. Multidisciplinary neuro-oncology boards review each case to recommend the safest modality.
| Approach or modality | Best suited to | Typical limits |
|---|---|---|
| Endoscopic endonasal resection | Midline anterior and sellar skull base tumors (e.g., pituitary adenomas, craniopharyngiomas, chordomas) | Limited lateral access beyond the internal carotid arteries; requires vascularised flap reconstruction to avoid CSF leaks |
| Open craniotomy (microsurgery) | Large, lateral or posterior fossa tumors (e.g., extensive vestibular schwannomas, petroclival meningiomas) | Requires temporary bone opening, external scalp incision, and carries longer initial tissue recovery |
| Stereotactic radiosurgery | Small residual or recurrent lesions (under 3 cm) and patients unfit for prolonged general anaesthesia | Does not provide rapid decompression of compressed optic nerves or brainstem; tumor shrinkage takes months to years |
Endoscopic corridors suit central lesions, avoiding facial scars and brain retraction; see our review of transnasal resection of tumor for technical comparisons. Open microsurgery remains essential for large, vascular or lateral tumors extending into the posterior fossa.
What happens during excision of skull base tumor step by step?
Skull base surgery follows five structured phases to ensure patient safety and precision throughout the procedure.
First, the patient receives general anaesthesia from a specialist neuro-anaesthetist. Intraoperative neurophysiological monitoring leads are placed to track cranial nerves (including facial and acoustic nerves) and motor pathways continuously.
Second, the head is positioned in a rigid fixation frame. The surgical team registers the patient's anatomy to computerised neuronavigation using pre-operative MRI and CT scans, providing real-time 3D instrument tracking.
Third, access is created. In an open approach, the surgeon makes a hairline incision and removes a small window of cranial bone. In an endoscopic approach, the nasal corridor is expanded and the sphenoid sinus opened.
Fourth, tumor resection proceeds under high magnification. The surgeon debulks the tumor centre with ultrasonic aspirators, then carefully dissects the capsule away from adjacent cranial nerves and cerebral arteries.
Fifth, the team ensures complete haemostasis and reconstructs the skull base in layers using tissue grafts, vascularised flaps and biological sealants to guarantee a watertight seal. The bone flap is secured with titanium plates, and incisions are closed.
Who is a suitable candidate for skull base tumor surgery?
Suitability is established through detailed neuro-imaging and clinical assessments. Favourable candidates have progressive tumor growth on serial MRI scans, symptomatic mass effect causing visual loss, cranial nerve palsies, persistent headaches, unmanageable endocrine disturbances, or lesions requiring tissue diagnosis. Candidates must also have adequate cardiopulmonary reserve to tolerate prolonged anaesthesia.
Surgery is usually deferred for small, stable, asymptomatic benign tumors discovered incidentally in older adults, where regular MRI surveillance is preferred. Patients with severe uncontrolled cardiovascular disease or bleeding disorders must be medically stabilised before major cranial surgery. For broader information on neurological surgical assessments, see our guide to neurosurgery treatments in Turkey.
Imaging before and after skull base surgery: what do scans show?
Unlike cosmetic treatments evaluated through clinical photographs, skull base tumor results are measured through high-resolution neuro-imaging and objective neurological evaluations.
Pre-operative contrast MRI and bone-window CT scans show the tumor's exact borders, arterial displacement, bone erosion and brainstem compression. Early post-operative MRI scans, performed within 48 to 72 hours of surgery, confirm the extent of resection, verify reconstructive flap position, and rule out haematoma or ischaemia.
Follow-up scans at three, six and twelve months track structural healing. They document decompression of neural pathways and re-expansion of brain tissue into the surgical space, alongside the gradual clearance of post-surgical fluid collections. Functional recovery, such as improved vision or headache relief, correlates with these structural improvements.
Hospital stay and excision of skull base tumor recovery timeline
Excision of skull base tumor recovery progresses through distinct clinical stages from intensive monitoring to rehabilitation at home.
The initial 24 to 48 hours take place in a dedicated neuro-intensive care unit (ICU), where nurses conduct hourly neurological checks, monitor fluid balances and administer intravenous pain relief and antibiotics. Once stable, the patient transfers to the neurosurgical ward for four to six days for gentle mobilisation, wound care and removal of nasal packs or drains.
International patients should plan for an overall stay in Turkey of 12 to 16 days. This allows for admission tests, the five- to eight-day hospital stay, and outpatient recovery in a hotel before travel. A final wound inspection, nasal endoscopy and flight clearance review are completed prior to departure.
At home, skull base surgery recovery continues for several months. Most people need 8 to 12 weeks away from work, avoiding strenuous activity, heavy lifting and nose-blowing. Energy levels and mild headaches improve over the first month, while full neurological healing and tissue stabilisation continue for 6 to 12 months.
Risks and potential complications of skull base surgery
Because skull base surgery operates within millimetres of vital brain centres and cranial nerves, patients must understand potential clinical risks. Authoritative organisations, including the NHS and the American Association of Neurological Surgeons (AANS), stress the importance of thorough risk discussions.
Cerebrospinal fluid (CSF) leakage occurs if the reconstructed skull base fails to form a watertight seal, presenting as watery discharge from the nose or wound. This requires head elevation, lumbar spinal drainage, or occasionally revision repair to prevent meningitis. Cranial nerve injuries can cause temporary or permanent facial weakness, numbness, double vision, swallowing difficulties, or hearing loss, depending on tumor position.
Vascular hazards include arterial injury, stroke, or venous thrombosis. Sellar tumors may trigger transient or permanent diabetes insipidus (fluid regulation issues) or pituitary hormone deficiencies requiring replacement medication. General surgical risks include deep vein thrombosis, wound infection and anaesthetic reactions.
How to choose a neurosurgical centre and questions to ask
Selecting a hospital for complex cranial surgery requires careful verification of standards, technology and clinical credentials. Look for an internationally accredited hospital (such as JCI) featuring an established neurosurgery department, computerised neuronavigation, intraoperative neuromonitoring and a dedicated neuro-ICU staffed 24/7 by neuro-intensivists.
Red flags include clinics that quote prices without reviewing high-resolution MRI or CT scans, facilities lacking dedicated neuro-ICUs, surgeons without specific skull base training, and coordinators who promise total tumor removal without discussing nerve preservation trade-offs. Learn about the planning process through how our process works, and submit your imaging for evaluation via our free quote page.
Consider asking these key questions during your consultation:
- How many skull base operations of my specific diagnosis does your team perform annually?
- Will my surgery involve a joint neurosurgical and ENT skull base team?
- What intraoperative neuromonitoring tools will be used during the operation?
- What reconstruction methods will you use to prevent cerebrospinal fluid leaks?
- What neuro-intensive care facilities and emergency protocols are in place?
- What aftercare and remote follow-up support are included once I return home?
Hospitals with Neurosurgery in Turkey
Frequently asked questions
Excision of skull base tumor is a complex neurosurgical procedure to remove abnormal growths from the underside of the skull and brain floor. Surgeons use minimally invasive endoscopic pathways through the nose or microsurgical craniotomies to access deep lesions while safeguarding adjacent cranial nerves and major cerebral arteries.
For benign lesions such as pituitary adenomas and vestibular schwannomas, complete surgical resection often provides a definitive, long-term cure. When tumors intimately involve critical blood vessels or cranial nerves, surgeons perform a safe subtotal removal followed by targeted radiosurgery to arrest tumor growth while preserving neurological function.
Approximate costs in Turkey typically range from €15,000 to €35,000, compared with €30,000 to €70,000 in the UK and upwards of €55,000 in the US. The price varies according to tumor complexity, surgical approach, operative duration, intensive care requirements and the specific neurosurgical technology used.
High-resolution pre-operative MRI and CT scans show the tumor's exact boundaries, vascular encasement and brain compression. Post-operative scans confirm the degree of tumor removal, verify skull base reconstruction integrity and show decompression of neural structures such as the optic chiasm, with brain tissue gradually expanding back into normal position.
Neither technique is universally suitable for every tumor. Endoscopic endonasal surgery suits midline anterior lesions like pituitary adenomas and chordomas, avoiding facial scars and brain retraction. Open craniotomy remains the standard approach for extensive, lateral or vascular tumors involving the posterior fossa and cerebellopontine angle where wider exposure is mandatory.
General anaesthesia ensures patients feel no sensation during surgery. Afterwards, surgical site discomfort and moderate headaches are common, but these are managed effectively with hospital pain medication. Because brain tissue itself lacks pain receptors, post-operative discomfort primarily stems from muscle healing, scalp incisions or nasal congestion following endoscopic approaches.
Patients typically spend one to two days in intensive care followed by four to six days on a neurosurgical ward. Resuming light daily activities takes approximately four to six weeks, while full recuperation and return to work usually take eight to twelve weeks, supported by gradual rehabilitation and outpatient monitoring.
Recurrence depends on tumor pathology, grade and whether complete resection was achieved. Benign tumors completely excised have very low recurrence rates. If residual tissue was intentionally preserved near vital nerves, routine annual MRI monitoring is conducted, with stereotactic radiosurgery employed if active regrowth is detected.
Skull base tumor excision is a major neurosurgical procedure carrying genuine clinical risks, including cerebrospinal fluid leakage, cranial nerve injury, stroke and infection. Modern advances, such as intraoperative neurophysiological monitoring, high-definition neuronavigation and specialised skull base reconstruction flaps, have significantly enhanced surgical safety in dedicated neurosurgical centres.
Patients should plan for a total stay of 12 to 16 days in Turkey. This window provides time for comprehensive pre-operative neuro-imaging, surgical hospitalisation of five to eight days (including ICU care), and sufficient outpatient recovery to confirm wound healing and absence of CSF leaks before flying home.
Patient stories